Only one patient within the non-relapsed cohort developed secondary autoimmunity (microscopic colitis) at 2 months post-AHSCT and this was reflected in a brief elevation in the concentration of cytokines at 3 months, such as IFNγ and IL-10. This evidence concerns the gene IL10 and Autoimmunity.